Drug Topics
NOVEMBER 14, 2023
For patients with polycystic ovary syndrome, 75% of whom have irregular or no ovulation, following a ketogenic diet improved IVF outcomes and metabolic health.
Pharmacy Times
NOVEMBER 14, 2023
Compared to the standard prenatal vitamin alone, vitamin D supplementation with the prenatal vitamin reduced the risk of asthma and wheezing in children by approximately 50%.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 14, 2023
Nirmatrelvir-ritonavir (Paxlovid) is an oral antiviral that inhibits the main protease of SARS-CoV-2 and is widely used in the United States.
STAT
NOVEMBER 14, 2023
A class action lawsuit was filed Tuesday against UnitedHealth Group and a subsidiary alleging that they are illegally using an algorithm to deny rehabilitation care to seriously ill patients, even though the companies know the algorithm has a high error rate. The class action suit, filed on behalf of deceased patients who had a UnitedHealthcare Medicare Advantage plan and their families by the California-based Clarkson Law Firm, follows the publication of a STAT investigation Tuesday.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Pharma
NOVEMBER 14, 2023
Earlier this month, Pfizer’s $3.5 billion cost-cutting campaign crossed overseas to Ireland. Now, just a week later, Pfizer is announcing hundreds more job cuts in the U.K. | Pfizer plans to cut approximately 500 roles and ax its Pharmaceutical Sciences Small Molecule capabilities at its site in Sandwich in Kent in the U.K. The move is a consequence of Pfizer’s enterprisewide cost realignment program, which the drugmaker unveiled in mid-October.
STAT
NOVEMBER 14, 2023
The nation’s largest health insurance company pressured its medical staff to cut off payments for seriously ill patients in lockstep with a computer algorithm’s calculations, denying rehabilitation care for older and disabled Americans as profits soared, a STAT investigation has found. UnitedHealth Group has repeatedly said its algorithm, which predicts how long patients will need to stay in rehab, is merely a guidepost for their recoveries.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 14, 2023
America’s trust in scientists and positive views of science has continued to decline, according to a new report. The Pew Research Center, a nonpartisan think tank, asked a random sample of 8,842 American adults this fall about their views on science and scientists. They found that roughly a quarter of Americans — 27% — said they have not too much or no confidence in scientists to act in the public’s best interests, compared to 12% who said the same in April 2020.
Fierce Healthcare
NOVEMBER 14, 2023
New York has proposed a slew of new cybersecurity regulations for the state’s hospitals and plans to funnel $500 million from its FY24 budget to help facilities upgrade their technology systems, Go | Should its proposal be finalized, the Empire State will give hospitals a year and access to a $500 million fund to bring their facilities into compliance.
STAT
NOVEMBER 14, 2023
WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry. “If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research.
Pharmacy Times
NOVEMBER 14, 2023
Homemade indoor air filters can trap and remove 99% of airborne viruses.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 14, 2023
In Stockton, California, almost 60% of the city’s 320,000 residents are prediabetic or living with diabetes. Shane Bailey, a 72-year-old longtime resident and U.S. Coast Guard veteran, is one of them. And because she lives in a neighborhood that is considered a food desert because it lacks nearby grocery stores, it can be a huge challenge to access healthy, affordable food.
Fierce Healthcare
NOVEMBER 14, 2023
Medicaid enrollment is projected to slide further next year, according to an annual budget survey of Medicaid officials conducted by KFF and Health Management Associates in collaboration with the N | State Medicaid directors once again see redeterminations as one of the biggest challenges they face heading into next year.
STAT
NOVEMBER 14, 2023
I want to bring your attention to a vitally important investigation STAT has published today. For more than a year, our reporters have documented how the use of artificial intelligence is driving denial of claims or delaying treatment for seriously ill patients. This latest story goes even deeper, establishing how the denial of claims was by design.
Pharmacy Times
NOVEMBER 14, 2023
Lessons from the pharmacy taught her about good communication. Now it’s her turn to educate pharmacists.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
NOVEMBER 14, 2023
Resilience, empathy, and gratitude. A personal battle with breast cancer. Mike.
STAT
NOVEMBER 14, 2023
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds in search of creatures to annoy and neighbors sleeping late. As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own hectic agendas.
pharmaphorum
NOVEMBER 14, 2023
AZ’s oncology hopes dented as Imfinzi flunks NSCLC trial Phil.
STAT
NOVEMBER 14, 2023
The announcement by the Center for Medicare and Medicaid Services that ten drugs will be subject to price negotiation under the Inflation Adjustment Act has unleashed a storm of debate. Most observers agree that the negotiations will reduce spending for both consumers and taxpayers. The real dispute centers on whether the prospect of price negotiations will reduce future innovation by shrinking the expected future profits for patented drugs.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
NOVEMBER 14, 2023
You’ve likely heard of Type 1 and Type 2 diabetes, but you may not have heard of this third type. Type 3 diabetes is a term used by some researchers to refer to emerging data that shows a link between insulin resistance and dysfunction of a hormone called insulin-like growth factor (IGF-1), which may be a causal factor in Alzheimer’s disease. Here is what we know so far about the connection between blood sugar and dementia.
STAT
NOVEMBER 14, 2023
PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.
Fierce Pharma
NOVEMBER 14, 2023
Johnson & Johnson and Bayer’s wide-spanning VOYAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD).
pharmaphorum
NOVEMBER 14, 2023
AHA: First data backs AskBio’s heart failure gene therapy Phil.
Fierce Healthcare
NOVEMBER 14, 2023
HCA Healthcare’s priorities are to address immediate issues with its physician professional fee spending, capitalize on its unexpectedly strong payer mix and volumes, and increase its longer term, | CFO Bill Rutherford said plans to spend billions on new inpatient and outpatient facilities across HCA's existing markets arrive as the for-profit system exits COVID amid a flurry of tailwinds—though one clear roadblock remains in Valesco Physician Services and costly professional fees.
European Pharmaceutical Review
NOVEMBER 14, 2023
The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. This ‘manifesto for growth’, developed by the Manufacturing Five (M5), a coalition of the UK’s leading advanced trade associations, proposed the reforms necessary for the UK to close the gap with global competitors and growth of innovative manufacturing in the country.
PioneerRx
NOVEMBER 14, 2023
The most wonderful time of the year is slowly approaching. Temperatures are falling, days are getting shorter (thanks, daylight savings), and holiday lights are.
European Pharmaceutical Review
NOVEMBER 14, 2023
In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass. On 1 October 2023, the final, official version of the chapter was published.
pharmaphorum
NOVEMBER 14, 2023
Autifony swings $770.5m deal with Jazz for CNS drugs Phil.
STAT
NOVEMBER 14, 2023
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Bon apétit, offsets are served Whenever lawmakers get around to actually making decisions about funding the government, leaders try to balance measures that save the government money with those that cost the government money.
pharmaphorum
NOVEMBER 14, 2023
Pharma’s engagement with HCPs evolving, finds new poll Phil.
Fierce Pharma
NOVEMBER 14, 2023
In little more than a decade, Boston’s transformed Seaport district—once littered with industrial buildings, warehouses and parking lots—has become an innovation hub and home to more than 25 health | Add another to the list of healthcare companies joining Boston's transformed Seaport district, as Merck KGaA's pharma subsidiary, EMD Serono, said it will move its U.S. headquarters from 25 miles south in Rockland to Seaport.
Pharmacy Times
NOVEMBER 14, 2023
Even with the current available treatment options, it is important to recognize the importance of masking, particularly for those with immunocompromised conditions.
Pharmafile
NOVEMBER 14, 2023
Ipsen and Medision Pharma have announced that Health Canada has approved Bylvay (odevixibat) for the treatment of pruritis in patients aged six months or older with Progressive Familial Intrahepatic Cholestasis (PFIC). Bylvay is the first medication approved in Canada for this indication. Both companies are part of a multiregional partnership in Canada and Israel in […] The post Health Canada approves Ipsen and Medision Pharma’s Bylvay for pruritus treatment appeared first on Pharmafile.
Pharmacy Times
NOVEMBER 14, 2023
According to the authors, these results contribute to developing information that associate lymphedema with localized changes in immunity and a susceptibility for cancer.
Expert insights. Personalized for you.
184 
Let's personalize your content